The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1977, 118: 291-295.
Copyright © 1977 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreth, H. W.
Right arrow Articles by ter Meulen, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kreth, H. W.
Right arrow Articles by ter Meulen, V.

Cell-Mediated Cytotoxicity Against Measles Virus in SSPE

I. Enhancement by Antibody1

Hans W. Kreth2 and Volker ter Meulen

From the Department of Pediatrics, University of Göttingen and Institute for Virology and Immunobiology, University of Würzburg

Abstract

In patients with subacute sclerosing panencephalitis (SSPE) virus persistency has been explained by a blocking factor of specific cell-mediated immunity in SSPE serum and cerebrospinal fluid (CSF). In the present study the effect of SSPE serum and CSF on cell-mediated cytotoxicity against 51Cr-labeled allogenic measles virus-infected target cells was tested.

Pretreatment of SSPE peripheral lymphoid cells by serum or CSF neither blocked nor increased measles-specific cytotoxicity when cells were subsequently tested in FCS containing tissue culture medium. However, killing activity was always enhanced after pretreatment of target cells or direct addition of serum or CSF to the cytotoxic assay. Enhancement was also observed with non-SSPE-derived measles antibodies. The effect was dependent on measles antibody concentrations. These results suggest that antibody-dependent killing by K cells is intact in patients with SSPE. It is possible that virus-infected brain cells are protected from an immune attack in vivo by antibody-induced antigenic modulation.

Footnotes

1 This work was supported by the Deutsche Forschungsgemeinschaft Kr 376/7 and Me 270/14.

2 Address reprint requests to Dr. H.W. Kreth, Universitäts-Kinderklinik, Humboldtallee 38, D-3400 Göttingen, W-Germany.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1977 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1977 by The American Association of Immunologists, Inc. All rights reserved.